Praveen K S joined CSBMM on October 2018. He have 5 years of experience in Research and Development department of biopharma industry, Biocon. He has contributed to the approval process of three biosimilars (these were first to be approved by FDA and EMA). He has demonstrated strong oral and written communications, and presentation skills with around 50+ technical reports/dossiers for regulatory submissions, publications in context to biopharmaceuticals (First author and Corresponding author) in peer-reviewed high impact journals, and several successful presentations (oral and poster) to international stakeholders, cross-functional CMC teams, and is a reviewer for various biopharma journals. Presently, developing novel analytical tools for high-throughput analysis of biopharmaceuticals, Data Independent acquisition strategies for Bottom-up tandem mass spectrometry analysis of HCPs, Sequence variants, proteomes, phospho-proteomes, multi-PTMs, and metabolomics.